Literature DB >> 15147189

Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein.

Qiulong Huang1, Liping Yu, Andrew M Petros, Angelo Gunasekera, Zhihong Liu, Nan Xu, Philip Hajduk, Jamey Mack, Stephen W Fesik, Edward T Olejniczak.   

Abstract

The severe acute respiratory syndrome (SARS) virus belongs to the Coronaviridea family of viruses. Its virion encodes several proteins including a replicase and four structural proteins. Here we describe the three-dimensional structure of the N-terminal domain of the SARS coronavirus (CoV) nucleocapsid protein. The protein consists of a five-stranded beta sheet with a folding topology distinct from other RNA-binding proteins. Single-stranded RNAs bind to the protein surface at the junction between a flexible, positively charged beta hairpin and the core structure. NMR-based screening was used to identify low molecular weight compounds that bind to this site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147189     DOI: 10.1021/bi036155b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  114 in total

Review 1.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

2.  Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein.

Authors:  Kumar Singh Saikatendu; Jeremiah S Joseph; Vanitha Subramanian; Benjamin W Neuman; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.

Authors:  Yong Hu; Wei Li; Ting Gao; Yan Cui; Yanwen Jin; Ping Li; Qingjun Ma; Xuan Liu; Cheng Cao
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs.

Authors:  Jeremiah S Joseph; Kumar Singh Saikatendu; Vanitha Subramanian; Benjamin W Neuman; Alexei Brooun; Mark Griffith; Kin Moy; Maneesh K Yadav; Jeffrey Velasquez; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  The murine coronavirus nucleocapsid gene is a determinant of virulence.

Authors:  Timothy J Cowley; Simon Y Long; Susan R Weiss
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

6.  Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription.

Authors:  Sonia Zúñiga; Jazmina L G Cruz; Isabel Sola; Pedro A Mateos-Gómez; Lorena Palacio; Luis Enjuanes
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging.

Authors:  Chung-Ke Chang; Yen-Lan Hsu; Yuan-Hsiang Chang; Fa-An Chao; Ming-Chya Wu; Yu-Shan Huang; Chin-Kun Hu; Tai-Huang Huang
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

8.  A rapid point of care immunoswab assay for SARS-CoV detection.

Authors:  Sriram Kammila; Dipankar Das; Pravin K Bhatnagar; Hoon H Sunwoo; Gustavo Zayas-Zamora; Malcolm King; Mavanur R Suresh
Journal:  J Virol Methods       Date:  2008-07-11       Impact factor: 2.014

9.  Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein.

Authors:  Chun-Yu Huang; Yen-Lan Hsu; Wan-Ling Chiang; Ming-Hon Hou
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

10.  Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes.

Authors:  Nicholas E Grossoehme; Lichun Li; Sarah C Keane; Pinghua Liu; Charles E Dann; Julian L Leibowitz; David P Giedroc
Journal:  J Mol Biol       Date:  2009-09-24       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.